Report topline data from the ANB030 Phase 1 healthy volunteer trial
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 25 Feb 2021
- Due
- 31 Jul 2021
- Checked
- 27 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“We anticipate topline data from our ongoing Phase 1 healthy volunteer clinical trial of ANB030 ... in mid-2021.”
What we found
Evidence strength A What the grades mean
The August 2021 filings, after the July 2021 deadline, show the ANB030 (rosnilimab) Phase 1 topline data had not been reported and was moved to Q4 2021.
-
A Anaptysbio, Inc. 8-K filed 2021-08-09
“Rosnilimab, previously referred to as ANB030, Phase 1 healthy volunteer top-line data and initiation of a Phase 2 trial in alopecia areata anticipated in Q4 2021” ✓ confirmed on the page
-
A Anaptysbio, Inc. 10-Q filed 2021-08-09
“We anticipate top-line safety, pharmacokinetic and receptor occupancy data from this Phase 1 clinical trial during the fourth quarter of 2021.” ✓ confirmed on the page
Checked 27 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- ANB030 Phase 1 healthy volunteer topline data
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Anaptysbio, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-ANAB-024540 · Corrections policy